Fasting levels of growth hormone are associated with carotid intima media thickness but are not affected by fluvastatin treatment
(2017) In BMC Cardiovascular Disorders 17(1).- Abstract
Background: Growth hormone (GH) has been linked to cardiovascular disease but the exact mechanism of this association is still unclear. We here test if the fasting levels of GH are cross-sectionally associated with carotid intima media thickness (IMT) and whether treatment with fluvastatin affects the fasting level of GH. Methods: We examined the association between GH and IMT in 4425 individuals (aged 46-68 years) included in the baseline examination (1991-1994) of the Malmö Diet and Cancer cardiovascular cohort (MDC-CC). From that cohort we then studied 472 individuals (aged 50-70 years) who also participated (1994-1999) in the β-Blocker Cholesterol-Lowering Asymptomatic Plaque Study (BCAPS), a randomized, double blind,... (More)
Background: Growth hormone (GH) has been linked to cardiovascular disease but the exact mechanism of this association is still unclear. We here test if the fasting levels of GH are cross-sectionally associated with carotid intima media thickness (IMT) and whether treatment with fluvastatin affects the fasting level of GH. Methods: We examined the association between GH and IMT in 4425 individuals (aged 46-68 years) included in the baseline examination (1991-1994) of the Malmö Diet and Cancer cardiovascular cohort (MDC-CC). From that cohort we then studied 472 individuals (aged 50-70 years) who also participated (1994-1999) in the β-Blocker Cholesterol-Lowering Asymptomatic Plaque Study (BCAPS), a randomized, double blind, placebo-controlled, single-center clinical trial. Using multivariate linear regression models we related the change in GH-levels at 12 months compared with baseline to treatment with 40 mg fluvastatin once daily. Results: In MDC-CC fasting values of GH exhibited a positive cross-sectional relation to the IMT at the carotid bulb independent of traditional cardiovascular risk factors (p = 0.002). In a gender-stratified analysis the correlation were significant for males (p = 0.005), but not for females (p = 0.09). Treatment with fluvastatin was associated with a minor reduction in the fasting levels of hs-GH in males (p = 0.05) and a minor rise in the same levels among females (p = 0.05). Conclusions: We here demonstrate that higher fasting levels of GH are associated with thicker IMT in the carotid bulb in males. Treatment with fluvastatin for 12 months only had a minor, and probably not clinically relevant, effect on the fasting levels of hs-GH.
(Less)
- author
- Hallengren, Erik
LU
; Almgren, Peter
LU
; Rosvall, Maria
LU
; Östling, Gerd
LU
; Persson, Margaretha
LU
; Bergmann, Andreas ; Struck, Joachim ; Engström, Gunnar LU ; Hedblad, Bo LU and Melander, Olle LU
- organization
-
- EXODIAB: Excellence of Diabetes Research in Sweden
- EpiHealth: Epidemiology for Health
- Cardiovascular Research - Hypertension (research group)
- Social Medicine and Health Policy (research group)
- Centre for Economic Demography
- Cardiovascular Research - Immunity and Atherosclerosis (research group)
- Internal Medicine - Epidemiology (research group)
- Cardiovascular Research - Epidemiology (research group)
- publishing date
- 2017-05-16
- type
- Contribution to journal
- publication status
- published
- subject
- keywords
- Cardiovascular disease, Growth hormone, Imt, Lipids, Statins
- in
- BMC Cardiovascular Disorders
- volume
- 17
- issue
- 1
- article number
- 125
- publisher
- BioMed Central (BMC)
- external identifiers
-
- pmid:28511669
- wos:000401701000001
- scopus:85019465217
- ISSN
- 1471-2261
- DOI
- 10.1186/s12872-017-0563-9
- language
- English
- LU publication?
- yes
- id
- da8876e3-f7d0-4bc6-a796-c96895beadf9
- date added to LUP
- 2017-07-03 15:56:29
- date last changed
- 2025-01-07 16:29:58
@article{da8876e3-f7d0-4bc6-a796-c96895beadf9, abstract = {{<p>Background: Growth hormone (GH) has been linked to cardiovascular disease but the exact mechanism of this association is still unclear. We here test if the fasting levels of GH are cross-sectionally associated with carotid intima media thickness (IMT) and whether treatment with fluvastatin affects the fasting level of GH. Methods: We examined the association between GH and IMT in 4425 individuals (aged 46-68 years) included in the baseline examination (1991-1994) of the Malmö Diet and Cancer cardiovascular cohort (MDC-CC). From that cohort we then studied 472 individuals (aged 50-70 years) who also participated (1994-1999) in the β-Blocker Cholesterol-Lowering Asymptomatic Plaque Study (BCAPS), a randomized, double blind, placebo-controlled, single-center clinical trial. Using multivariate linear regression models we related the change in GH-levels at 12 months compared with baseline to treatment with 40 mg fluvastatin once daily. Results: In MDC-CC fasting values of GH exhibited a positive cross-sectional relation to the IMT at the carotid bulb independent of traditional cardiovascular risk factors (p = 0.002). In a gender-stratified analysis the correlation were significant for males (p = 0.005), but not for females (p = 0.09). Treatment with fluvastatin was associated with a minor reduction in the fasting levels of hs-GH in males (p = 0.05) and a minor rise in the same levels among females (p = 0.05). Conclusions: We here demonstrate that higher fasting levels of GH are associated with thicker IMT in the carotid bulb in males. Treatment with fluvastatin for 12 months only had a minor, and probably not clinically relevant, effect on the fasting levels of hs-GH.</p>}}, author = {{Hallengren, Erik and Almgren, Peter and Rosvall, Maria and Östling, Gerd and Persson, Margaretha and Bergmann, Andreas and Struck, Joachim and Engström, Gunnar and Hedblad, Bo and Melander, Olle}}, issn = {{1471-2261}}, keywords = {{Cardiovascular disease; Growth hormone; Imt; Lipids; Statins}}, language = {{eng}}, month = {{05}}, number = {{1}}, publisher = {{BioMed Central (BMC)}}, series = {{BMC Cardiovascular Disorders}}, title = {{Fasting levels of growth hormone are associated with carotid intima media thickness but are not affected by fluvastatin treatment}}, url = {{http://dx.doi.org/10.1186/s12872-017-0563-9}}, doi = {{10.1186/s12872-017-0563-9}}, volume = {{17}}, year = {{2017}}, }